Latest news

  • Linking a common stomach bug to gastric cancer

    Why does a common bug, Helicobacter pylori, which is present in the stomachs of around half the world’s population, drive stomach cancer in some people? Associate Professor Richard Ferrero will establish how this seemingly innocuous bacterium drives growth of a specific type of stomach tumour, thanks to generous funding from the US Department of Defense.…  Read more

  • Disease of moving parts: examining the puzzle of cancer

    For more than 50 years, the idea that cancer is caused by abnormal genes has been driving cancer research and treatment. Now, discovery research into epigenetics (how genes are switched on and off), inflammation and tissue organisation (the interaction between cells and organs) is leading scientists to acknowledge that just like the human body, cancer…  Read more

  • 2018 Fielding Foundation Fellowship and Innovation Award announced

    Hudson Institute’s brightest scientific minds and most promising discoveries will be progressed, thanks to support from a leading philanthropist, Mr Peter Fielding and the Fielding Foundation. The 2018 Fielding Innovation Award has been awarded to Dr Maree Bilandzic to develop more effective treatments for women with ovarian cancer. The 2018 Fielding Foundation Fellowship has been…  Read more

  • Could gut bacteria be harnessed to help fight cancer?

    The gut microbiome, the vast ecosystem of bacteria that live within our digestive system, is becoming increasingly recognised for its essential role in supporting our physical and mental health. Now, two new studies from the US are showing that the composition of a patient’s gut bacteria could determine how likely they are to respond to…  Read more

  • Being born late preterm linked to increased heart disease risk in adulthood

    Babies born at 35 weeks could be at higher risk of cardiovascular disease in adult life than those born at full term, according to new research by Hudson Institute of Medical Research scientists. The scientists found that being born late preterm (35 – 36 weeks gestation) was linked to a decrease in regulation by the…  Read more

  • Harnessing immune therapies to combat pancreatic cancer

    Investigating the role of the immune system in the fight against pancreatic cancer is the focus of innovative research at Hudson Institute, thanks to new funding announced on World Pancreatic Cancer Day (Thursday, 16 November). The Avner Pancreatic Cancer Foundation has awarded an Innovation Grant to Professor Brendan Jenkins, one of six separate projects funded…  Read more

  • Professor Henry Burger AO awarded Doctor of Medical Science honoris causa

    Hudson Institute Director Emeritus and Distinguished Scientist, Professor Henry Burger AO, has been awarded a Doctor of Medical Science honoris causa from the University of Melbourne. The Honour was conferred in recognition of Prof Burger’s significant contributions to the area of reproductive endocrinology, his leadership and prominence in the development and support of clinical initiatives…  Read more

  • Paving the way for an endometrial cancer early detection test

    New research from Hudson Institute of Medical Research is paving the way for a world-first early detection test for endometrial cancer that could reduce mortality and potentially spare women from an invasive hysterectomy. A study led by Professor Guiying Nie and first author Dr Sophea Heng, a Cancer Council Victoria Postdoctoral Cancer Research Fellow, has identified…  Read more

  • Clamping the umbilical cord later saves preterm babies’ lives

    Thousands of preterm babies could be saved by waiting 60 seconds before clamping the umbilical cord after birth instead of clamping it immediately – according to two international studies, including research from Hudson Institute, Monash University and Monash Health. Our researchers provided the scientific understanding for this major global study that will see a change to…  Read more

  • 2017 L’Oréal-UNESCO for Women in Science Fellowship

    Dr Jaclyn Pearson from the Centre for Innate Immunity and Infectious Diseases has been named as a L’Oréal-UNESCO For Women in Science 2017 Australian Fellow. The prestigious fellowship recognises Dr Pearson’s contribution to science and will support her career progression. Read about what has inspired Dr Pearson and her work. Dr Jaclyn Pearson stems her…  Read more